Ogden Christopher
CytomX Therapeutics, Inc. · Chief Financial Officer
Ogden Christopher is listed in filings as Chief Financial Officer at CytomX Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 19, 2026, including sale activity. Recent filings connect the profile to CytomX Therapeutics, Inc. (CTMX). The current snapshot covers public activity from Jun 14, 2024 to Mar 19, 2026. Reported amounts are shown as $124.1K to $226.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $29k10.6k shares | SellJun 16, 2025 | $2.69 | $3.81 | |
| $4.8k1.6k shares | SellJun 13, 2025 | $2.95 | $3.81 | |
| $5.1k8.6k shares | SellMar 18, 2025 | $0.599 | $3.81 | |
| $2.4k2k shares | SellAug 20, 2024 | $1.23 | $3.81 |